Tobias Gaemelke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tobias Gaemelke has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Lars Grondahl Hvid
Exercise Biology, Department of Public Health, Aarhus University, Denmark
5 shared publications Ulrik Dalgas
Exercise Biology, Department of Public Health, Aarhus University, Aarhus, Denmark
4 shared publications- Ulrik Dalgas
Aarhus University
4 shared publications - Morten Riemenschneider
Exercise Biology, Dept. of Public Health, Aarhus University, Aarhus C, Denmark
3 shared publications - Simon Fristed Eskildsen
CFIN, Aarhus Hospital
3 shared publications Lars G. Hvid
Exercise Biology, Department of Public Health, Aarhus University, Aarhus, Denmark
2 shared publications
Latest Publications
- Open Access
- 15 May 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 111, 107254
Association of brain structure and motor function in older persons with multiple sclerosis and healthy controls: A cross-sectional study
- 15 May 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 111, 107254
Open AccessAssociation of brain structure and motor function in older persons with multiple sclerosis and healthy controls: A cross-sectional study
- 15 June 2025
- Published by BMJ in British Journal of Sports Medicine
- Vol. 59 (17) , 1261-1262
Power Training in Older People with Multiple Sclerosis – the PoTOMS trial (PhD Academy Award)
- 15 June 2025
- Published by BMJ in British Journal of Sports Medicine
- Vol. 59 (17) , 1261-1262
Power Training in Older People with Multiple Sclerosis – the PoTOMS trial (PhD Academy Award)
- Open Access
Persons with multiple sclerosis reveal distinct kynurenine pathway metabolite patterns: a multinational cross-sectional study
Neuroaxonal damage in multiple sclerosis (MS) results from an interplay of neurotoxic pathomechanisms combined with a reduced neuroprotective capacity of neurons and glia to resist neurotoxic damage. Kynurenine pathway (KP) imbalance resembles some of the molecular mechanisms central to the incompletely understood MS pathophysiology. To study the role of the KP in MS, we performed targeted metabolomics on serum samples from 353 persons with MS and 111 healthy individuals, and detected MS-specific differences in concentrations of most kynurenines. Using exploratory factor analysis, we then identified two distinct KP metabolite patterns: the inflammation-driven neurotoxic pattern „NeuroTox“ and the neuroprotective pattern „NeuroPro“. Our results show that greater „NeuroTox“ and lower „NeuroPro“ were associated with higher disease severity. The novelty of our data-driven approach that identified distinct KP metabolite patterns in MS advocates for future studies using comparable approaches to investigate whether KP imbalance follows similar disease-specific patterns in diseases other than MS.
Open AccessPersons with multiple sclerosis reveal distinct kynurenine pathway metabolite patterns: a multinational cross-sectional study
Neuroaxonal damage in multiple sclerosis (MS) results from an interplay of neurotoxic pathomechanisms combined with a reduced neuroprotective capacity of neurons and glia to resist neurotoxic damage. Kynurenine pathway (KP) imbalance resembles some of the molecular mechanisms central to the incompletely understood MS pathophysiology. To study the role of the KP in MS, we performed targeted metabolomics on serum samples from 353 persons with MS and 111 healthy individuals, and detected MS-specific differences in concentrations of most kynurenines. Using exploratory factor analysis, we then identified two distinct KP metabolite patterns: the inflammation-driven neurotoxic pattern „NeuroTox“ and the neuroprotective pattern „NeuroPro“. Our results show that greater „NeuroTox“ and lower „NeuroPro“ were associated with higher disease severity. The novelty of our data-driven approach that identified distinct KP metabolite patterns in MS advocates for future studies using comparable approaches to investigate whether KP imbalance follows similar disease-specific patterns in diseases other than MS.
- 13 February 2025
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 39 (5) , 377-385
Early Phase Multiple Sclerosis Patients Present Substantial Deficits in Physical-, Cognitive-, and Patient-reported Outcomes Compared to Matched Healthy Controls
Background: Early identification of potential deficits is of utmost importance as early diagnosis and early treatment has been shown to be crucial to reduce disease activity and disease impact—leading to the notion of “Time matters” in multiple sclerosis (MS). Objective: The aim of the present study was to compare physical-, cognitive-, and patient-reported outcomes in early phase MS patients with matched healthy controls (HC). Methods: This cross-sectional study included 84 patients early in the disease course of MS (≤2 years from diagnosis) and 84 age- and sex-matched HC. All participants underwent a comprehensive test battery including physical-, cognitive-, and patient-reported outcomes. Results: Relative deficits for patients with MS compared to HC corresponded to 7% to 35% in walking capacity (Timed 25-Foot Walk Test, 6 Spot Step Test, 6 Minute Walk Test), 5% for upper limb function (9 Hole Peg Test), 27% for aerobic capacity (maximal oxygen uptake), 17% to 38% for physical activity level (Baecke Sport Index and accelerometer counts/minute), 68% for fatigability (Walking Fatigability Index), 150% for fatigue (Modified Fatigue Impact Scale), 4% to 20% for cognitive function (Symbol Digit Modalities Test, Paced Auditory Serial Addition Test, and Selective Reminding Test), and lastly, 7% to 8% for quality of life (Short Form-36 health survey). Only the Symbol Digit Modalities Test and Selective Reminding Test Delayed did not differ between groups, statistically. Conclusion: Early phase MS patients present substantial deficits in physical-, cognitive-, and patient-reported outcomes compared to HC. These early impairments highlight the importance of early initiatives aimed at preserving and/or building of reserve capacity.
- 13 February 2025
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 39 (5) , 377-385
Early Phase Multiple Sclerosis Patients Present Substantial Deficits in Physical-, Cognitive-, and Patient-reported Outcomes Compared to Matched Healthy Controls
Background: Early identification of potential deficits is of utmost importance as early diagnosis and early treatment has been shown to be crucial to reduce disease activity and disease impact—leading to the notion of “Time matters” in multiple sclerosis (MS). Objective: The aim of the present study was to compare physical-, cognitive-, and patient-reported outcomes in early phase MS patients with matched healthy controls (HC). Methods: This cross-sectional study included 84 patients early in the disease course of MS (≤2 years from diagnosis) and 84 age- and sex-matched HC. All participants underwent a comprehensive test battery including physical-, cognitive-, and patient-reported outcomes. Results: Relative deficits for patients with MS compared to HC corresponded to 7% to 35% in walking capacity (Timed 25-Foot Walk Test, 6 Spot Step Test, 6 Minute Walk Test), 5% for upper limb function (9 Hole Peg Test), 27% for aerobic capacity (maximal oxygen uptake), 17% to 38% for physical activity level (Baecke Sport Index and accelerometer counts/minute), 68% for fatigability (Walking Fatigability Index), 150% for fatigue (Modified Fatigue Impact Scale), 4% to 20% for cognitive function (Symbol Digit Modalities Test, Paced Auditory Serial Addition Test, and Selective Reminding Test), and lastly, 7% to 8% for quality of life (Short Form-36 health survey). Only the Symbol Digit Modalities Test and Selective Reminding Test Delayed did not differ between groups, statistically. Conclusion: Early phase MS patients present substantial deficits in physical-, cognitive-, and patient-reported outcomes compared to HC. These early impairments highlight the importance of early initiatives aimed at preserving and/or building of reserve capacity.
- Open Access
- 25 November 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 93, 106190
Sarcopenia in older people with multiple sclerosis: A cross-sectional study
- 25 November 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 93, 106190
Open AccessSarcopenia in older people with multiple sclerosis: A cross-sectional study
- Open Access
- 19 February 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 38, 101279
Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the “power training in older multiple sclerosis patients (PoTOMS) randomized control trial
- 19 February 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 38, 101279
Open AccessEffects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the “power training in older multiple sclerosis patients (PoTOMS) randomized control trial
- Open Access
- 30 November 2023
- Published by Elsevier in Experimental Gerontology
- Vol. 184, 112339
The combined deleterious effects of multiple sclerosis and ageing on neuromuscular function
- 30 November 2023
- Published by Elsevier in Experimental Gerontology
- Vol. 184, 112339
Open AccessThe combined deleterious effects of multiple sclerosis and ageing on neuromuscular function
- Open Access
- 3 October 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 68, 104198
Participant characteristics of existing exercise studies in persons with multiple sclerosis – A systematic review identifying literature gaps
- 3 October 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 68, 104198
Open AccessParticipant characteristics of existing exercise studies in persons with multiple sclerosis – A systematic review identifying literature gaps
- 22 May 2021
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 35 (7) , 644-653
Comparison Between Isometric and Concentric Motor Fatigability in Persons With Multiple Sclerosis and Healthy Controls – exploring central and peripheral contributions of motor fatigability
Background: Motor fatigability (i.e. contraction-induced reduction in muscle strength) from a concentric task associate stronger to walking and perception of fatigue in persons with multiple sclerosis (pwMS), compared with an isometric task. However, the central and peripheral contributions of motor fatigability between these tasks have not been investigated. Objective: Compare the central and peripheral contributions of motor fatigability in the knee extensors in a sustained isometric fatigability protocol versus a concentric fatigability protocol and in pwMS versus healthy controls (HCs). Methods: Participants (n=31 pwMS; n=15 HCs) underwent neuromuscular testing before and immediately after two knee extensor fatigability tasks (sustained isometric and concentric) in an isokinetic dynamometer. Neuromuscular testing of fatigability consisted of maximal voluntary contraction, voluntary activation (central/neural contributor), and resting twitch (peripheral/muscular contributor) determined by the interpolated twitch technique. Results: Sustained isometric and concentric fatigability protocols resulted in motor fatigability for both pwMS and HCs, with no between-protocols differences for either group. Regression analysis showed that motor fatigability variance in pwMS was mainly attributed to central fatigability in the sustained isometric protocol and to both central and peripheral fatigability in the concentric protocol. In HCs, the variance in sustained isometric and concentric fatigability were attributed to both peripheral and central fatigability. Conclusion: Central and peripheral contributions of motor fatigability differed between sustained isometric and concentric protocols as well as between pwMS and HCs. These between-protocol differences in pwMS provide a neuromuscular dimension to the reported difference in the strength of associations of concentric and isometric tasks to walking and perception of fatigue in pwMS.
- 22 May 2021
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 35 (7) , 644-653
Comparison Between Isometric and Concentric Motor Fatigability in Persons With Multiple Sclerosis and Healthy Controls – exploring central and peripheral contributions of motor fatigability
Background: Motor fatigability (i.e. contraction-induced reduction in muscle strength) from a concentric task associate stronger to walking and perception of fatigue in persons with multiple sclerosis (pwMS), compared with an isometric task. However, the central and peripheral contributions of motor fatigability between these tasks have not been investigated. Objective: Compare the central and peripheral contributions of motor fatigability in the knee extensors in a sustained isometric fatigability protocol versus a concentric fatigability protocol and in pwMS versus healthy controls (HCs). Methods: Participants (n=31 pwMS; n=15 HCs) underwent neuromuscular testing before and immediately after two knee extensor fatigability tasks (sustained isometric and concentric) in an isokinetic dynamometer. Neuromuscular testing of fatigability consisted of maximal voluntary contraction, voluntary activation (central/neural contributor), and resting twitch (peripheral/muscular contributor) determined by the interpolated twitch technique. Results: Sustained isometric and concentric fatigability protocols resulted in motor fatigability for both pwMS and HCs, with no between-protocols differences for either group. Regression analysis showed that motor fatigability variance in pwMS was mainly attributed to central fatigability in the sustained isometric protocol and to both central and peripheral fatigability in the concentric protocol. In HCs, the variance in sustained isometric and concentric fatigability were attributed to both peripheral and central fatigability. Conclusion: Central and peripheral contributions of motor fatigability differed between sustained isometric and concentric protocols as well as between pwMS and HCs. These between-protocol differences in pwMS provide a neuromuscular dimension to the reported difference in the strength of associations of concentric and isometric tasks to walking and perception of fatigue in pwMS.